[1]
|
Fardet, L., Flahault, A., Kettaneh, A., Tiev, K.P., Généreau, T., Tolédano, C., et al. (2007) Corticosteroid-Induced Clinical Adverse Events: Frequency, Risk Factors and Patient’s Opinion. British Journal of Dermatology, 157, 142-148. https://doi.org/10.1111/j.1365-2133.2007.07950.x
|
[2]
|
Coutinho, A.E. and Chapman, K.E. (2011) The Anti-Inflammatory and Immunosuppressive Effects of Glucocorticoids, Recent Developments and Mechanistic Insights. Molecular and Cellular Endocrinology, 335, 2-13. https://doi.org/10.1016/j.mce.2010.04.005
|
[3]
|
Clark, A.R. (2007) Anti-Inflammatory Functions of Glucocorticoid-Induced Genes. Molecular and Cellular Endocrinology, 275, 79-97. https://doi.org/10.1016/j.mce.2007.04.013
|
[4]
|
Buttgereit, F., Burmester, G. and Lipworth, B.J. (2005) Optimised Glucocorticoid Therapy: The Sharpening of an Old Spear. The Lancet, 365, 801-803. https://doi.org/10.1016/s0140-6736(05)17989-6
|
[5]
|
Schacke, H. (2002) Mechanisms Involved in the Side Effects of Glucocorticoids. Pharmacology & Therapeutics, 96, 23-43. https://doi.org/10.1016/s0163-7258(02)00297-8
|
[6]
|
Kleiman, A. and Tuckermann, J.P. (2007) Glucocorticoid Receptor Action in Beneficial and Side Effects of Steroid Therapy: Lessons from Conditional Knockout Mice. Molecular and Cellular Endocrinology, 275, 98-108. https://doi.org/10.1016/j.mce.2007.05.009
|
[7]
|
Spies, C.M., Strehl, C., van der Goes, M.C., Bijlsma, J.W.J. and Buttgereit, F. (2011) Glucocorticoids. Best Practice & Research Clinical Rheumatology, 25, 891-900. https://doi.org/10.1016/j.berh.2011.11.002
|
[8]
|
Fardet, L., Kassar, A., Cabane, J. and Flahault, A. (2007) Corticosteroid-Induced Adverse Events in Adults: Frequency, Screening and Prevention. Drug Safety, 30, 861-881. https://doi.org/10.2165/00002018-200730100-00005
|
[9]
|
Nassar, K., Janani, S., Roux, C., Rachidi, W., Etaouil, N. and Mkinsi, O. (2014) La corticothérapie systémique au long cours: Représentations des patients, perceptions des prescripteurs et observance thérapeutique. Revue du Rhumatisme, 81, 49-53. https://doi.org/10.1016/j.rhum.2013.04.008
|
[10]
|
Zomalheto, Z., Dossou-yovo, H., Zossoungbo, F. and Avimadjè, M. (2015) Prévalence des complications de la corticothérapie chez les sujets ouest-africains consultant en rhumatologie. Pan African Medical Journal, 21, Article No. 304. https://doi.org/10.11604/pamj.2015.21.304.5805
|
[11]
|
Diakité, F., Kodio, B., Touré, S., Sangaré, F., Touré, M. and Cissé, I. (2022) Tolérance de la corticothérapie par voie générale en rhumatologie au CHU Gabriel Touré de Bamako. SARh/SBR, 202, 67.
|
[12]
|
Kamissoko, A.B., Diallo, M.L., Oniankitan, S., Balde, S., Toure, M., Yombouno, E., Toure, M., Barry, A., Conde, K. and Oniankitan, O. (2019) Prise en charge des rhumatismes inflammatoires chroniques en Guinée. Journal de la Recherche Scientifique de l’Université de Lomé, 21, 385-392.
|
[13]
|
Kellgren, J.H., Jeffrey, M.R. and Ball, J. (1963) The Epidemiology of Chronic Rheumatism. Blackwell Scientific Publications, 326-327.
|
[14]
|
Linden, S.V.D., Valkenburg, H.A. and Cats, A. (1984) Evaluation of Diagnostic Criteria for Ankylosing Spondylitis. Arthritis & Rheumatism, 27, 361-368. https://doi.org/10.1002/art.1780270401
|
[15]
|
Hochberg, M.C. (1997) Updating the American College of Rheumatology Revised Criteria for the Classification of Systemic Lupus Erythematosus. Arthritis & Rheumatism, 40, 1725-1725. https://doi.org/10.1002/art.1780400928
|
[16]
|
Manthorpe, R., Oxholm, P., Prause, J.U. and Schiödt, M. (1986) The Copenhagen Criteria for Sjögren’s Syndrome. Scandinavian Journal of Rheumatology, 61, 19-21.
|
[17]
|
Fox, R.I., Robinson, C.A., Curd, J.G., Kozin, F. and Howelly, F.V. (1986) Sjögren’s Syndrome. Proposed Criteria for Classification. Arthritis & Rheumatism, 29, 577-585. https://doi.org/10.1002/art.1780290501
|
[18]
|
Arnett, F.C., Edworthy, S.M., Bloch, D.A., Mcshane, D.J., Fries, J.F., Cooper, N.S., et al. (1988) The American Rheumatism Association 1987 Revised Criteria for the Classification of Rheumatoid Arthritis. Arthritis & Rheumatism, 31, 315-324. https://doi.org/10.1002/art.1780310302
|
[19]
|
Aletaha, D., Neogi, T., Silman, A.J., Funovits, J., Felson, D.T., Bingham, C.O., et al. (2010) 2010 Rheumatoid Arthritis Classification Criteria: An American College of Rheumatology/European League against Rheumatism Collaborative Initiative. Annals of the Rheumatic Diseases, 69, 1580-1588. https://doi.org/10.1136/ard.2010.138461
|
[20]
|
Jordan, K.M. (2003) EULAR Recommendations 2003: An Evidence Based Approach to the Management of Knee Osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Annals of the Rheumatic Diseases, 62, 1145-1155. https://doi.org/10.1136/ard.2003.011742
|
[21]
|
Davatchi, F., Assaad-Khalil, S., Calamia, K.T., Crook, J.E., Sadeghi-Abdollahi, B., Schirmer, M., et al. (2013) The International Criteria for Behçet’s Disease (ICBD): A Collaborative Study of 27 Countries on the Sensitivity and Specificity of the New Criteria. Journal of the European Academy of Dermatology and Venereology, 28, 338-347. https://doi.org/10.1111/jdv.12107
|
[22]
|
Bennett, P.H. and Burch, T.A. (1968) Population Studies of the Rheumatic Diseases. Excerpta Medica Foundation, 456-457.
|
[23]
|
Lamchahab, F.E., Reffas, W., Bouattar, T., Abdellaoui, E.K., Ouzeddoun, N., Bayahia, R., et al. (2012) Mesures adjuvantes à une corticothérapie systémique prolongée: Que faut-il prescrire? Annales Pharmaceutiques Françaises, 70, 292-297. https://doi.org/10.1016/j.pharma.2012.07.007
|
[24]
|
Badra, K.A., Lamine, D.M., Marie, T., Alhassane, D., Emmanuel, Y., Abdoulaye, B., et al. (2018) Panorama Des Maladies Rhumatismales A Conakry. European Scientific Journal, 14, 422. https://doi.org/10.19044/esj.2018.v14n24p422
|
[25]
|
Damiano, J. (2020) Infiltrations intra-articulaires périphériques de corticoïdes. Revue du Rhumatisme Monographies, 87, 141-145. https://doi.org/10.1016/j.monrhu.2020.01.001
|
[26]
|
Perdoncini-Roux, A., Blanchon, T., Hanslik, T., Lasserre, A., Turbelin, C., Dorleans, Y., et al. (2009) Perception par les médecins généralistes de la gêne induite par les effets indésirables d’une corticothérapie systémique prolongée. Revue d’Épidémiologie et de Santé Publique, 57, 93-97. https://doi.org/10.1016/j.respe.2008.12.009
|
[27]
|
Bouvard, B., Legrand, E., Audran, M. and Chappard, D. (2011) Ostéoporose secondaire à la corticothérapie systémique. Revue du Rhumatisme Monographies, 78, 69-75. https://doi.org/10.1016/j.monrhu.2011.02.005
|
[28]
|
Valat, J. and Rozenberg, S. (2008) Les infiltrations de corticoïde dans les lombosciatiques et les lombalgies communes. Revue du Rhumatisme, 75, 590-595. https://doi.org/10.1016/j.rhum.2008.02.007
|
[29]
|
Abidi, I., Rifai, K., Iraqi, H. and Gharbi, M.E.H. (2021) Récupération totale de l’axe corticotrope après une automédication à la dexaméthasone pendant 24 ans. Annales d’Endocrinologie, 82, 419. https://doi.org/10.1016/j.ando.2021.08.476
|